Document is current
Any future updates will be listed below
-
Authors
Chen, Kai
Chen, Yixing
Ren, Yingxue https://orcid.org/0000-0003-4529-5722
Wang, Zhen
Huang, Ya https://orcid.org/0000-0002-9056-527X
Pan, Meixia
Li, Zonghua https://orcid.org/0000-0001-5242-9608
Casey, Monica Castanedes
Qiao, Wenhui
Shi, Ji
Kong, Dehui
Xhafkollari, Gisela https://orcid.org/0000-0003-2486-7576
Santhakumar, Hannah https://orcid.org/0009-0008-4851-4437
Wetmore, Allison M.
Thompson, E. Aubrey https://orcid.org/0000-0002-9001-4240
Wang, Xusheng https://orcid.org/0000-0002-1759-9588
Dickson, Dennis W. https://orcid.org/0000-0001-7189-7917
Holtzman, David M. https://orcid.org/0000-0002-3400-0856
Bu, Guojun https://orcid.org/0000-0003-3491-1016
Han, Xianlin https://orcid.org/0000-0002-8615-2413
Peng, Junmin https://orcid.org/0000-0003-0472-7648
-
Funding
Funding for this research was provided by:
Cure Alzheimer's Fund
Foundation for the National Institutes of Health (U19AG069701)
- License Information
-
More Information
Article History
Received: 7 January 2026
Accepted: 23 September 2026
First Online: 8 October 2026
Ethics
Competing interests: D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics. D.M.H. is on the scientific advisory boards of Denali, Genentech, Cajal Neuroscience, and Switch and consults for Pfizer, Novartis, and Roche. G.B. is a consultant for SciNeuro Pharmaceuticals. All the other authors declare no competing interests.
